The global biotechnology market size is expected to reach USD 727.1 billion by 2025, at a CAGR of 7.4% according to a new report by Grand View Research, Inc. The emergence of certain key themes in the market is expected to drive growth in this industry to a lucrative extent.
These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases while recommending clinical trials.
For PDF sample Copy or More Details please visit link @: http://www.grandviewresearch.com/industry-analysis/biotechnology-market
Supportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Developed economies such as the U.K. and the U.S. are critically monitoring and funding synthetic biology R&D initiatives. For example, in 2010, a six months’ review of synthetic biology headed by a panel of expert scientists was enforced by the U.S. President and subsequently conducted a hearing of the Energy and Commerce Committee exclusively concerning synthetic biology.
Further key findings from the report suggest:
• Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period
• Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the biotechnology market
• Decreasing costs and rise in the number of services in this segment are expected to drive the segment with lucrative revenue
• North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in a larger share
• Introduction of technologically advanced products and presence of various biotechnology-based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are some of the factors that are attributive to the growth of the sector
• Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products
• Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in the area of regenerative medicine
• Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S, Novartis AG, Sanofi Aventis, and Lonza
To request research report sample copy with TOC please visit @: https://www.grandviewresearch.com/industry-analysis/biotechnology-market/request/rs1
Grand View Research has segmented the biotechnology market on the basis of technology, application, and region:
Biotechnology Technology Outlook (Revenue, USD Million; 2014 - 2025)
• DNA Sequencing
• Nanobiotechnology
• Tissue engineering and Regeneration
• Fermentation
• Cell-Based Assay
• PCR Technology
• Chromatography Market
• Others
Biotechnology Application Outlook (Revenue, USD Million; 2014 - 2025)
• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others
Biotechnology Regional Outlook (Revenue, USD Million; 2014 - 2025)
• North America
o The U.S.
o Canada
• Europe
o Germany
o The U.K.
• Asia Pacific
o Japan
o China
• Latin America
o Brazil
• The Middle East and Africa (MEA)
o South Africa
For Inquire before buying please visit @: https://www.grandviewresearch.com/inquiry/369/ibb
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.